UnitedHealth to sell Change Healthcare's claims business for $2.2 billion
Reuters
Published Apr 25, 2022 09:52AM ET
Updated Apr 25, 2022 11:50AM ET
(Reuters) -UnitedHealth Group has agreed to sell Change Healthcare (NASDAQ:CHNG)'s claims editing business for $2.2 billion in a move some analysts say could ease regulatory hurdles in the way of an $8 billion merger between the healthcare companies.
Earlier this year, the U.S. Department of Justice (DoJ) sued to stop the acquisition for giving UnitedHealth (NYSE:UNH) access to competitors' data, forcing the companies to extend the deal's closing date by nine months to Dec. 31.
The sale of the claims business, to private equity firm TPG Capital, will only go through once UnitedHealth's acquisition of Change is complete, Change said in a regulatory filing. https://www.sec.gov/ix?doc=/Archives/edgar/data/1756497/000119312522116452/d574197d8k.htm
UnitedHealth and Change offer competing softwares for processing healthcare claims and together serve 38 of the top 40 health insurers in the country, the DoJ said in its complaint in February.
Owning Change's claims business, ClaimsXten, would offer UnitedHealth a window into rival health plans at Humana Inc (NYSE:HUM), Anthem Inc
Citi analyst Daniel Grosslight said the sale of the claims business will likely remove the DoJ's argument against the merger, and potentially increase the probability of the deal going through.
"We do not think this will reduce the value of Change to UnitedHealth as there is significant overlap between ClaimsXten and Optum's PI solution," Grosslight wrote in a note.
Optum is UnitedHealth's health services unit which will absorb Change if the acquisition is completed.
UnitedHealth, which has said it would fight the lawsuit, did not have any further comments on the deal beyond the regulatory filing.
Shares of Change Healthcare were up 1.03% at $23.8, while UnitedHealth fell about 1% to $515.70.
"It looks like the market is betting that this transaction could grease the wheels of getting the deal done, considering the Change share movement today in a down market," Morningstar analyst Julie Utterback told Reuters.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.